Back to Search
Start Over
[Radiation recall dermatitis after oral cyclophosphamide].
- Source :
-
Revue medicale de Liege [Rev Med Liege] 2009 Apr; Vol. 64 (4), pp. 179-81. - Publication Year :
- 2009
-
Abstract
- Radiation recall dermatitis is an inflammatory skin reaction occurring in a previously irradiated field following the delivery of a promoting agent. It has been described after a number of antineoplastic agents such as gemcitabine, taxanes, anthracyclines. We report the case of a 50-year-old man with metastatic prostate cancer who developed two consecutive radiation recall dermatitis episodes triggered by oral cyclophosphamide. They occurred 4 to 5 weeks after palliative radiotherapy on bone metastasis. Spontaneous resolution was observed within 6 weeks after discontinuation of cyclophosphamide and with local supportive care. To our knowledge this is the first reported case of radiation recall dermatitis after oral cyclophosphamide.
- Subjects :
- Adenocarcinoma drug therapy
Adenocarcinoma radiotherapy
Adenocarcinoma secondary
Administration, Oral
Antineoplastic Agents, Alkylating administration & dosage
Bone Neoplasms drug therapy
Bone Neoplasms radiotherapy
Bone Neoplasms secondary
Chemotherapy, Adjuvant adverse effects
Combined Modality Therapy
Cyclophosphamide administration & dosage
Humans
Male
Middle Aged
Palliative Care
Prostatic Neoplasms drug therapy
Prostatic Neoplasms pathology
Prostatic Neoplasms radiotherapy
Radiodermatitis etiology
Radiotherapy, Adjuvant adverse effects
Adenocarcinoma therapy
Antineoplastic Agents, Alkylating adverse effects
Bone Neoplasms therapy
Cyclophosphamide adverse effects
Prostatic Neoplasms therapy
Radiodermatitis chemically induced
Subjects
Details
- Language :
- French
- ISSN :
- 0370-629X
- Volume :
- 64
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Revue medicale de Liege
- Publication Type :
- Academic Journal
- Accession number :
- 19514535